Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
18h agoen
From the article
Conditions : HCC - Hepatocellular Carcinoma; Chinese Herbal Medicine; ICG (Indocyanine Green); Overall Survival (All-cause Mortality); Quality of Life Interventions : Drug: Shuganhuazhuo Formula; Drug: Targeted therapy; Drug: Immunotherapy; Drug: Chemotherapy; Procedure: TACE; Procedure: HAIC Sponsors : Xiang-Qian; HerbMed Group Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
两部门：推动境内保险机构在再保险登记交易中心进行再保险合同、赔付等信息统一登记
36氪·2d ago
以岭药业：厄贝沙坦化学原料药上市申请获批
36氪·3d ago
Hong Jae Chon: Integrating Systemic Therapy in the Earlier Stages of Liver Cancer
OncoDaily·1d ago
麦科医药MT1002完成Ib/II期首例入组，卒中“双管线”布局加速推进
36氪·4d ago
Scientific Study: Traditional Chinese Herbal Extract (Herbalene) Shows Immune Restoration Potential in Cancer Patients
This article presents a scientific study examining the in vitro effects of aqueous extracts from two traditional Chinese medicinal herbs (in
sirjasonwinters.com·19d agoScipher picks up Chemomab’s liver disease drug, Nasdaq listing in all-stock merger
Fierce Biotech·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.